Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Class A Stock
- Total 13F shares
- 54,909,739
- Total 13F value
- $1,262,978,377
- Share change
- +7,941,005
- Put/Call ratio
- 29%
- SEC-reported price per share
- $23.01
- Number of holders
- 82
- Value change
- +$181,552,159
- Number of buys
- 58
- Number of sells
- 17
- Shares outstanding
- 525,302,736
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
82
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75629V104
Recent filing periods:
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 3.5%
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 3.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership
Top 5
BAILLIE GIFFORD & CO
3.5%
Laurion Capital Management LP
0.73%
VANGUARD GROUP INC
0.51%
ARK Investment Management LLC
0.45%
FMR LLC
0.42%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
3.5%
|
$676,017,000
18,521,000 shares
|
— | 30 Jun 2021 |
| Laurion Capital Management LP |
13F
Company
|
0.73%
|
$140,839,000
3,858,617 shares
|
— | 30 Jun 2021 |
| VANGUARD GROUP INC |
13F
Company
|
0.51%
|
$97,934,000
2,683,107 shares
|
— | 30 Jun 2021 |
| ARK Investment Management LLC |
13F
Company
|
0.45%
|
$86,822,000
2,378,675 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
0.42%
|
$80,724,000
2,211,601 shares
|
— | 30 Jun 2021 |
| HARVARD MANAGEMENT CO INC |
13F
Company
|
0.29%
|
$55,088,000
1,509,254 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
82
Shares
54,909,739
Rows available
82
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
75
Q3 2021 holders
82
Holder diff
7
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend